Implementation Guide CH VACD
6.0.0 - trial-use
This page is part of the CH VACD (R4) (v6.0.0: STU 6) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Profile: CH VACD Immunization
Author of the content: PractitionerRole
CH VACD Extension Immunization Medication Reference: Medication FSME-IMMUN CC Inj Susp sep Nadel
CH VACD Extension verificationStatus: SNOMED CT: 59156000 (Confirmed)
identifier: urn:oid:2.999.1.2.3.4/7f7a308a-63f7-4be1-a329-0a33e08b4645
status: Completed
vaccineCode: FSME-Immun CC
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-08-01
recorded: 2021-08-02 00:00:00+0200
lotNumber: 12-34244
route: Intramuscular use
| Actor |
| PractitionerRole |
note: By Practitioner/TC-HCP2-C2 @2021-08-01
Der Patient hatte keinerlei Nebenwirkungen.
| TargetDisease | DoseNumber[x] |
| Tickborne encephalitis | 1 |